EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
01 1Chinoin Pharmaceuticals and Chemical Works Private Co., Ltd.
02 1EUROAPI Hungary Ltd.
03 1Farmak, a,s
04 2Dipharma Francis Srl
05 1Embio Limited
06 1Fagron Inc
07 1LETCO MEDICAL, LLC
08 1Medisca Inc.
09 1Professional Compounding Centers of America
10 1Tianish Laboratories Private Limited
01 1SELEGILINE HYDROCHLORIDE
02 2Selegiline
03 2Selegiline HCl
04 6Selegiline Hydrochloride
01 1Czech Republic
02 2France
03 2India
04 2Italy
05 1Netherlands
06 2U.S.A
07 1United Kingdom
NDC Package Code : 45542-1146
Start Marketing Date : 1989-06-06
End Marketing Date : 2026-01-19
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
NDC Package Code : 63278-0102
Start Marketing Date : 1997-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 82231-113
Start Marketing Date : 1989-06-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0642
Start Marketing Date : 2012-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0062
Start Marketing Date : 2012-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60646-106
Start Marketing Date : 2021-04-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0882
Start Marketing Date : 2009-01-04
End Marketing Date : 2025-05-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 62991-1135
Start Marketing Date : 2009-10-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2792
Start Marketing Date : 2015-05-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0129
Start Marketing Date : 2021-06-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
A Selegiline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Selegiline, including repackagers and relabelers. The FDA regulates Selegiline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Selegiline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Selegiline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Selegiline supplier is an individual or a company that provides Selegiline active pharmaceutical ingredient (API) or Selegiline finished formulations upon request. The Selegiline suppliers may include Selegiline API manufacturers, exporters, distributors and traders.
click here to find a list of Selegiline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Selegiline as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Selegiline API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Selegiline as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Selegiline and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Selegiline NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Selegiline suppliers with NDC on PharmaCompass.
We have 9 companies offering Selegiline
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?